Sight Sciences Inc (SGHT)
Sight Sciences stock today
Sight Sciences closed at $9.32 on October 30, 2026, down 2.61% on the day. Over the past year it returned +83.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $507 million.
| Period | SGHT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -0.4% | -0.9% |
| 3 months | +77.2% | +2.1% |
| Year to date | +17.5% | +11.7% |
| 1 year | +83.5% | +12.4% |
| 3 years | +517.2% | +88.5% |
| 5 years | -65.4% | +76.0% |
Key statistics
- Market value
- $507M
- Price / sales
- 6.1
- 52-week range
- $3.45 to $9.57
- Next report
- Nov 4, 2026
About Sight Sciences
Develops medical devices for eye surgery and ophthalmology treatments.
Sector: Health Care
More on Sight Sciences
- Financials: revenue, earnings and segmentsRevenue -3% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $345.57 today
No forecast, no recommendation. This page describes Sight Sciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.